ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

AUA 2012

American Urological Association (AUA)aua
2012 Annual Meeting

May 19 - 23, 2012
Georgia World Congress Center
Atlanta, GA USA

AUA 2012 - About UroToday and Digital Science Press

Learn about UroToday, UIJ, and Digital Science Press and why we are the world's leading resource for urology news:

 

 

roberts 1

roberts 2

roberts 3

roberts 4

roberts 5

roberts 6

 

 

AUA 2012 - European Randomized Study of Screening for Prostate Cancer (ERSPC): An update after 11 years of follow-up - Slide Presentation

ATLANTA, GA USA (UroToday) - Presented by Monique Roobol, PhD* (on behalf of the ERSPC Study Group) at the American Urological Association (AUA) Annual Meeting- May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA

Read more...

AUA 2012 - Making sense of all the new options: Pragmatic considerations in CRPC - Slide Presentation

ATLANTA, GA USA (UroToday) - Presented by Oliver Sartor, MD* at the American Urological Association (AUA) Annual Meeting - May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA

Read more...

AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Another Perspective

ATLANTA, GA USA (UroToday) -

Aligning Treatment Goals Involves Patient-Physician Dialog

An interesting podium presentation by Brad Davidson, et al. addressed the absence of goal setting between metastatic prostate cancer (mCRPC) patients and their physicians. Keystone to this conversation is mutually defining the phrases “quality of life” versus “quantity of life.” Studies by Fowler (JAMA 2000) and Smith (J Supportive Oncology 2011) both reported patients are not distressed by prognostic and treatment information.

The researchers sought to understand how mCRPC patients and their physicians mutually discuss treatment goals. Clinic visits were videotaped with patient-physician consent. Of the 42-mCRPC clinic visits of which 69% were African American patients, 7 urologists and 7 oncologists were involved. In all of these visits, the discussion about patient goals for therapy or the terminal nature of their disease never took place. Physicians were interviewed by the research team following the patient visit and completed a standardized questionnaire. The urologists and oncologists in this study prioritized the care plan by preserving “quality of life.” In contrast, the patients were also independently interviewed and completed a questionnaire. These patients identified “quantify of life” to be most important. Both groups assumed their treatment goals were aligned. The absence of dialog engulfed the differences.

This study emphasizes the need to enhance communication between the patient and physician aligning treatment goals and defining expectations.

This study was support by Janssen Scientific Affairs.

Presented by Brad Davidson, Matthew DiChiara, Robert A Bailey, Lorie A Ellis, Mekre’ Senbetta, Andrew J Stephenson, and Tracey L Krupski at the American Urological Association (AUA) Annual Meeting - May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA

View full AUA Coverage

 


AUA 2012 - Does long-term aspirin use lower serum PSA levels? – Results from the Duke Prostate Center - Session Highlights

ATLANTA, GA USA (UroToday) -

Pre-operative Aspirin users have lower Serum PSA level than Non-users

The Duke Prostate Cancer Center study (Abstract 2237) investigated whether long-term aspirin use lowers serum PSA levels. Aspirin has been shown to be associated with reduced risk for several cancers including colorectal cancer. The group sought to understand the pharmacologic influence of aspirin on PSA levels.

The study group involved 931 men with prostate cancer undergoing prostatectomy. These men had known aspirin maintenance use prior to surgery. The group used a Mann-Whitney test to determine associations of aspirin use with PSA levels. Results showed 325 men (35%) were prescribed aspirin prior to the surgery. Aspirin users tended to be older and Caucasian compared to non-users. After controlling various clinical and pathological confounders, aspirin use was significantly associated with lower PSA levels. The mean-adjusted PSA for aspirin users was 4.95 and for non-users 5.41. The 8.5% reduction in aspirin users needs to be verified in other radical prostatectomy cohorts and men without prostate cancer.

 

Presented by Cagri Senocak, Lionel Banez, Jean-Alfred Thomas, Roberto Muller, Leah Gerber, Cary Robertson, Thomas Polascik, Stephen Freedland, Philip Walther, and Judd Moul at the American Urological Association (AUA) Annual Meeting - May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA

View full AUA Coverage

 


AUA 2012 - Unilateral prostate cancer: Analysis of predictors in search and Duke Prostate Center databases - Session Highlights

ATLANTA, GA USA (UroToday) -

Predictors for Prostate Cancer Candidate Selection

Read more...

AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD

ATLANTA, GA USA (UroToday) - The burden of prostate cancer in the U.S. and Europe remains significant despite the fact that overall mortality has improved. Prostate cancer remains the second leading cause of cancer death in men.

Read more...

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Press Briefing

ATLANTA, GA USA (UroToday) - Is there an association between male baldness and prostate cancer? In men, male pattern baldness is very common, with nearly 75% of men over age 40 experiencing some degree of baldness.

Read more...

AUA 2012 - Genetic variants associated with severity of lower urinary tract symptoms and prostate cancer susceptibility - Press Release

ATLANTA, GA USA (PRESS RELEASE) - May 22, 2012 - Certain genetic variants, specifically rs1571801 and rs5945572, appear to promote, and rs445114 protects against increasing lower urinary tract symptoms (LUTS), according to a new study at the 107th Annual Scientific Meeting of the American Urological Association (AUA).

Read more...

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Video Lecture

ATLANTA, GA USA (UroToday) - Presented by Neil E Fleshner, MD, FRCSC, MPH* at the American Urological Association (AUA) Annual Meeting - May 19 - 23, 2012 - Georgia World Congress Center - Atlanta, GA USA

Read more...

Page 1 of 6